Delivery Order SPE2DR25D1100-SPE2DR26FCX4B
- Not listed
- The Defense Logistics Agency awarded a $36,136.31 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector units on December 5, 2025, with a completion deadline of December 8, 2025. This firm fixed-price delivery order represents a direct purchase of this specialty pharmaceutical product for use within federal medical supply chains. The contract was competitively awarded with no set-aside provisions, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency awarded a $5,378.11 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with a completion date of December 9, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on December 8, 2025. The place of performance is AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs....
- The Defense Logistics Agency awarded a $62,114.93 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of May 20, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $5,827.97 to AmerisourceBergen Drug Corp for the supply of ENBREL 50 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a non-competitive delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $46,872.38 by the Defense Logistics Agency (DLA) on December 22, 2025, for the supply of ENBREL 50 mg/ml SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 23, 2025, and represents a child order under a larger indefinite delivery contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $47,976.98 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of ENBREL 50 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price contract carries an ultimate completion date of December 3, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside provisions were applied to this award. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $37,564.58 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of May 6, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement for pharmaceutical delivery to support federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $97,675.01 to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with an ultimate completion date of December 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single purchase order under AmerisourceBergen's existing contract vehicle with the DLA. This...
- The Defense Logistics Agency awarded a $19,854.83 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors. The contract was competitively awarded with no set-aside designation and is scheduled for completion by December 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, supplying a comprehensive range of medications and medical supplies to...
- The Defense Logistics Agency awarded a $15,555.78 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of December 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The delivery will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCX4BDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,149.59 on January 2, 2026, for the supply of ENBREL 50 mg/ml SureClick auto-injectors, with completion scheduled for January 5, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child order under AmerisourceBergen's larger federal pharmaceutical supply vehicle. The contractor will perform the delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's extensive federal contract portfolio demonstrates its capacity to fulfill specialized medical procurement requirements across multiple therapeutic domains, positioning it as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 1/1/26 |